Target intelligence / Profile preview

Pseudouridine synthase 7 like (PUS7L)

Target
PUS7L
Molecular classification
Enzyme (RNA-modifying enzyme; specifically, a pseudouridine synthase)
01

Overview

Pseudouridine synthase 7 like (PUS7L) is a human protein encoded by the PUS7L gene, classed among the pseudouridine synthase enzyme family. It is presumed to catalyze the isomerization of uridine to pseudouridine in RNA, a widespread post-transcriptional modification important for RNA stability and function. While PUS7 (the closely related enzyme) is well studied and modifies a broad array of RNAs regulating cellular adaptation and development, PUS7L's specific substrates, cellular functions, and disease associations remain poorly defined. It shares structural similarity and predicted function with other pseudouridine synthases, but unique roles or mechanisms attributed exclusively to PUS7L have not been extensively documented. No pharmaceuticals are reported to interact with PUS7L, and there is no evidence for its use as a clinical biomarker. PUS7L is considered a valid molecular target for RNA modification studies, but its biological significance and potential as a therapeutic target require further investigation.

Other names
Pseudouridylate synthase PUS7LDKFZP434G1415Pseudouridylate synthase 7 homolog-like proteinPUS7L
02

Mechanism of action

Not established (mechanisms would likely mirror those of pseudouridine synthases whereby inhibitors could hypothetically block pseudouridylation, but no such agents or mechanisms for PUS7L are described)

03

Biological functions

RNA modification (pseudouridylation)Possibly involved in mRNA pseudouridylation, although the full substrate spectrum and physiological roles are not yet completely defined
04

Disease associations

Other (no direct disease associations reported for PUS7L; most research and disease associations pertain to PUS7, where mutations are linked to defects in development and brain function; extrapolation for PUS7L not demonstrated in literature)
05

Safety considerations

None reported (no known safety concerns or therapeutic challenges specific to targeting PUS7L)
06

Interacting drugs

None known (no drugs are currently reported to interact with PUS7L)
07

Biomarkers

None established (no use as biomarker for patient selection or efficacy is described)

Beyond the preview

Go deeper on Pseudouridine synthase 7 like (PUS7L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudouridine synthase 7 like (PUS7L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call